You have free access to this content

British Journal of Clinical Pharmacology

Cover image for Vol. 57 Issue 5

May 2004

Volume 57, Issue 5

Pages 535–691

  1. Editors's View

    1. Top of page
    2. Editors's View
    3. Editors's Report
    4. Review
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Pharmacokinetics/pharmacodynamics
    8. Drug interactions
    9. Drug distribution
    10. Adverse drug reactions
    11. Therapeutics
    12. Short Reports
    13. Book Reviews
    14. Letters to the Editor
    1. You have free access to this content
      Characterizing variability in cardiovascular drug responses (pages 535–537)

      Richard Donnelly

      Version of Record online: 16 APR 2004 | DOI: 10.1111/j.1365-2125.2004.02148.x

      • image
  2. Editors's Report

    1. Top of page
    2. Editors's View
    3. Editors's Report
    4. Review
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Pharmacokinetics/pharmacodynamics
    8. Drug interactions
    9. Drug distribution
    10. Adverse drug reactions
    11. Therapeutics
    12. Short Reports
    13. Book Reviews
    14. Letters to the Editor
    1. You have free access to this content
      The British Journal of Clinical Pharmacology Editors’ Report for 2003 (pages 538–539)

      Jeffrey K. Aronson, Martin S. Lennard, James M. Ritter, Nigel S. Baber and Evan J. Begg

      Version of Record online: 16 APR 2004 | DOI: 10.1111/j.1365-3125.2004.02149.x

  3. Review

    1. Top of page
    2. Editors's View
    3. Editors's Report
    4. Review
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Pharmacokinetics/pharmacodynamics
    8. Drug interactions
    9. Drug distribution
    10. Adverse drug reactions
    11. Therapeutics
    12. Short Reports
    13. Book Reviews
    14. Letters to the Editor
    1. You have free access to this content
      Drug metabolism and ageing (pages 540–544)

      M. T. Kinirons and M. S. O'Mahony

      Version of Record online: 16 APR 2004 | DOI: 10.1111/j.1365-2125.2004.02096.x

  4. Pharmacodynamics

    1. Top of page
    2. Editors's View
    3. Editors's Report
    4. Review
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Pharmacokinetics/pharmacodynamics
    8. Drug interactions
    9. Drug distribution
    10. Adverse drug reactions
    11. Therapeutics
    12. Short Reports
    13. Book Reviews
    14. Letters to the Editor
    1. You have free access to this content
      The I1-imidazoline agonist moxonidine decreases sympathetic tone under physical and mental stress (pages 545–551)

      René R. Wenzel, Anna Mitchell, Winfried Siffert, Sandra Bührmann, Thomas Philipp and Rafael F. Schäfers

      Version of Record online: 23 MAR 2004 | DOI: 10.1111/j.1365-2125.2003.02058.x

      • image
      • image
      • image
    2. You have free access to this content
      Modelling the cardiovascular effects of ephedrine (pages 552–562)

      Adam M. Persky, N. Seth Berry, Gary M. Pollack and Kim L. R. Brouwer

      Version of Record online: 23 MAR 2004 | DOI: 10.1111/j.1365-2125.2003.02062.x

      • image
      • image
      • image
      • image
      • image
      • image
      • image
  5. Pharmacokinetics

    1. Top of page
    2. Editors's View
    3. Editors's Report
    4. Review
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Pharmacokinetics/pharmacodynamics
    8. Drug interactions
    9. Drug distribution
    10. Adverse drug reactions
    11. Therapeutics
    12. Short Reports
    13. Book Reviews
    14. Letters to the Editor
    1. You have free access to this content
      Tissue pharmacokinetics of levofloxacin in human soft tissue infections (pages 563–568)

      Romuald Bellmann, Gerald Kuchling, Pejman Dehghanyar, Markus Zeitlinger, Erich Minar, Bernhard X. Mayer, Markus Müller and Christian Joukhadar

      Version of Record online: 23 MAR 2004 | DOI: 10.1111/j.1365-2125.2004.02059.x

      • image
    2. You have free access to this content
      Effects of various factors on steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone: lack of impact of MDR-1 genotypes (pages 569–575)

      Norio Yasui-Furukori, Kazuo Mihara, Takenori Takahata, Akihito Suzuki, Taku Nakagami, Ronald De Vries, Tomonori Tateishi, Tsuyoshi Kondo and Sunao Kaneko

      Version of Record online: 23 MAR 2004 | DOI: 10.1111/j.1365-2125.2003.02061.x

    3. You have free access to this content
  6. Pharmacokinetics/pharmacodynamics

    1. Top of page
    2. Editors's View
    3. Editors's Report
    4. Review
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Pharmacokinetics/pharmacodynamics
    8. Drug interactions
    9. Drug distribution
    10. Adverse drug reactions
    11. Therapeutics
    12. Short Reports
    13. Book Reviews
    14. Letters to the Editor
    1. You have free access to this content
      Single-dose FTY720 pharmacokinetics, food effect, and pharmacological responses in healthy subjects (pages 586–591)

      John M. Kovarik, Robert Schmouder, Denise Barilla, Yibin Wang and Gerolf Kraus

      Version of Record online: 23 MAR 2004 | DOI: 10.1111/j.1365-2125.2003.02065.x

      • image
      • image
      • image
  7. Drug interactions

    1. Top of page
    2. Editors's View
    3. Editors's Report
    4. Review
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Pharmacokinetics/pharmacodynamics
    8. Drug interactions
    9. Drug distribution
    10. Adverse drug reactions
    11. Therapeutics
    12. Short Reports
    13. Book Reviews
    14. Letters to the Editor
    1. You have free access to this content
      Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects (pages 592–599)

      Xuemin Jiang, Kenneth M. Williams, Winston S. Liauw, Alaina J. Ammit, Basil D. Roufogalis, Colin C. Duke, Richard O. Day and Andrew J. McLachlan

      Version of Record online: 3 FEB 2004 | DOI: 10.1111/j.1365-2125.2003.02051.x

      • image
      • image
  8. Drug distribution

    1. Top of page
    2. Editors's View
    3. Editors's Report
    4. Review
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Pharmacokinetics/pharmacodynamics
    8. Drug interactions
    9. Drug distribution
    10. Adverse drug reactions
    11. Therapeutics
    12. Short Reports
    13. Book Reviews
    14. Letters to the Editor
    1. You have free access to this content
  9. Adverse drug reactions

    1. Top of page
    2. Editors's View
    3. Editors's Report
    4. Review
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Pharmacokinetics/pharmacodynamics
    8. Drug interactions
    9. Drug distribution
    10. Adverse drug reactions
    11. Therapeutics
    12. Short Reports
    13. Book Reviews
    14. Letters to the Editor
    1. You have free access to this content
      Frequency and characteristics of hospital admissions associated with drug-related problems in paediatrics (pages 611–615)

      Kylie L. Easton, Colin B. Chapman and Jo-anne E. Brien

      Version of Record online: 3 FEB 2004 | DOI: 10.1111/j.1365-2125.2003.02052.x

    2. You have free access to this content
  10. Therapeutics

    1. Top of page
    2. Editors's View
    3. Editors's Report
    4. Review
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Pharmacokinetics/pharmacodynamics
    8. Drug interactions
    9. Drug distribution
    10. Adverse drug reactions
    11. Therapeutics
    12. Short Reports
    13. Book Reviews
    14. Letters to the Editor
    1. You have free access to this content
      Furosemide responsiveness, non-adherence and resistance during the chronic treatment of heart failure: a longitudinal study (pages 622–631)

      Robert J. MacFadyen, J. Christopher Gorski, D. Craig Brater and Allan D. Struthers

      Version of Record online: 3 FEB 2004 | DOI: 10.1111/j.0306-5251.2003.02054.x

      • image
      • image
      • image
      • image
      • image
    2. You have free access to this content
      Comparison of once-daily nifedipine controlled-release with twice-daily nifedipine retard in the treatment of essential hypertension (pages 632–639)

      Junichi Minami, Atsushi Numabe, Norikazu Andoh, Naohiko Kobayashi, Shigeo Horinaka, Toshihiko Ishimitsu and Hiroaki Matsuoka

      Version of Record online: 3 FEB 2004 | DOI: 10.1111/j.1365-2125.2003.02056.x

      • image
      • image
    3. You have free access to this content
      Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes (pages 640–651)

      Bernard M. Y. Cheung, Ian J. Lauder, Chu-Pak Lau and Cyrus R. Kumana

      Version of Record online: 23 MAR 2004 | DOI: 10.1111/j.1365-2125.2003.02060.x

      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image
  11. Short Reports

    1. Top of page
    2. Editors's View
    3. Editors's Report
    4. Review
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Pharmacokinetics/pharmacodynamics
    8. Drug interactions
    9. Drug distribution
    10. Adverse drug reactions
    11. Therapeutics
    12. Short Reports
    13. Book Reviews
    14. Letters to the Editor
    1. You have free access to this content
      Effect of duloxetine on tolterodine pharmacokinetics in healthy volunteers (pages 652–656)

      Teng C. Hua, Alan Pan, Clark Chan, Yeo K. Poo, Michael H. Skinner, Mary P. Knadler, Celedon R. Gonzales and Stephen D. Wise

      Version of Record online: 23 MAR 2004 | DOI: 10.1111/j.1365-2125.2004.02068.x

      • image
    2. You have free access to this content
      An investigation of components of variance and tachyphylaxis in a placebo-controlled intravenous tyramine study (pages 657–660)

      M. V. Cantarini, C. L. Watkins, J. Growcott and A. M. Hughes

      Version of Record online: 23 MAR 2004 | DOI: 10.1111/j.1365-2125.2004.02069.x

      • image
  12. Book Reviews

    1. Top of page
    2. Editors's View
    3. Editors's Report
    4. Review
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Pharmacokinetics/pharmacodynamics
    8. Drug interactions
    9. Drug distribution
    10. Adverse drug reactions
    11. Therapeutics
    12. Short Reports
    13. Book Reviews
    14. Letters to the Editor
    1. You have free access to this content
      The Maudsley 2003 Prescribing Guidelines (page 661)

      E. Szabadi

      Version of Record online: 23 MAR 2004 | DOI: 10.1111/j.1365-2125.2004.02066.x

    2. You have free access to this content
      The Practice of Medicinal Chemistry (page 662)

      P. Jeffrey

      Version of Record online: 23 MAR 2004 | DOI: 10.1111/j.1365-2125.2004.02080.x

  13. Letters to the Editor

    1. Top of page
    2. Editors's View
    3. Editors's Report
    4. Review
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Pharmacokinetics/pharmacodynamics
    8. Drug interactions
    9. Drug distribution
    10. Adverse drug reactions
    11. Therapeutics
    12. Short Reports
    13. Book Reviews
    14. Letters to the Editor
    1. You have free access to this content
      Genotyping of the A6986G polymorphism of CYP3A5 (page 663)

      Johanna Weiss and Walter E. Haefeli

      Version of Record online: 31 OCT 2003 | DOI: 10.1046/j.1365-2125.2003.02006.x

      • image
    2. You have free access to this content
      CYP3A5 phenotype-genotype correlations in a British population (page 664)

      Ann K. Daly and Barry P. King

      Version of Record online: 16 APR 2004 | DOI: 10.1111/j.1365-2125.2004.02091.x

    3. You have free access to this content
      Erratum (page 664)

      Version of Record online: 16 APR 2004 | DOI: 10.1111/j.1365-2125.2004.02099.x

    4. You have free access to this content

SEARCH

SEARCH BY CITATION